Form D · Other Technology
Double Blind Bio Inc.
San Francisco, CA · CIK 0002102510
Offering snapshot reported Dec 29, 2025 · SEC filing
- Reported sold
- $5.62M Offering amount: $5.62M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 29, 2025 | Initial | $5,619,999 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-568107
Source: Form D, filed Dec 29, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Hughes | Director, Executive |
| Shruti Tibrewala | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
187 16 Th Avenue
San Francisco, CA, 94118
San Francisco, CA, 94118